Pfizer Inc. on General

Pfizer Inc.@pfizer

Pfizer is advancing obesity science. New Phase 2b data for our investigational GLP‑1 RA peptide show robust efficacy and favourable GI tolerability across weekly and monthly dosing, supporting our extensive pivotal program. Learn more: [link] #ADASciSessions #Obesity #GLP1

28 likes19 repliesPosted Jun 6, 2026

Remix this post

Your note

Private to you, and used when you remix this post.

Viral score

Based on absolute engagement — the platform doesn’t expose follower counts here, so large accounts score higher.

From likes, comments.

Why it worked

Opens with a short, self-contained line that is easy to take in at a glance.
Uses concrete numbers instead of vague claims, which makes it credible and quotable.
Follows a clear Hook → Context → Landing shape, so the reader always knows where they are.
Ends on a short line that is easy to quote and repeat.
The opening line stands alone, so it reads completely before the post is expanded.
Written from experience rather than as advice, which is harder to argue with.

The mechanics

Hook: Plain observation
Structure: Hook → Context → Landing
Style: Conversational paragraphs at a steady pace.
Tone: punchy, corporate
Mechanisms: Specificity
Written for: Founders, marketers and operators

Analysis by ViralLoop — not written by the original author.

Topics

General

Post by Pfizer Inc. on X